1. Home
  2. EDSA vs ISPO Comparison

EDSA vs ISPO Comparison

Compare EDSA & ISPO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EDSA
  • ISPO
  • Stock Information
  • Founded
  • EDSA 2015
  • ISPO 2010
  • Country
  • EDSA Canada
  • ISPO United States
  • Employees
  • EDSA N/A
  • ISPO N/A
  • Industry
  • EDSA Biotechnology: Pharmaceutical Preparations
  • ISPO Blank Checks
  • Sector
  • EDSA Health Care
  • ISPO Finance
  • Exchange
  • EDSA Nasdaq
  • ISPO Nasdaq
  • Market Cap
  • EDSA 13.8M
  • ISPO 44.3M
  • IPO Year
  • EDSA N/A
  • ISPO N/A
  • Fundamental
  • Price
  • EDSA $2.09
  • ISPO $3.52
  • Analyst Decision
  • EDSA Strong Buy
  • ISPO
  • Analyst Count
  • EDSA 2
  • ISPO 0
  • Target Price
  • EDSA $13.00
  • ISPO N/A
  • AVG Volume (30 Days)
  • EDSA 13.1K
  • ISPO 35.9K
  • Earning Date
  • EDSA 08-08-2025
  • ISPO 08-12-2025
  • Dividend Yield
  • EDSA N/A
  • ISPO N/A
  • EPS Growth
  • EDSA N/A
  • ISPO N/A
  • EPS
  • EDSA N/A
  • ISPO N/A
  • Revenue
  • EDSA N/A
  • ISPO $265,499,000.00
  • Revenue This Year
  • EDSA N/A
  • ISPO N/A
  • Revenue Next Year
  • EDSA N/A
  • ISPO $148.67
  • P/E Ratio
  • EDSA N/A
  • ISPO N/A
  • Revenue Growth
  • EDSA N/A
  • ISPO N/A
  • 52 Week Low
  • EDSA $1.55
  • ISPO $3.11
  • 52 Week High
  • EDSA $5.59
  • ISPO $9.31
  • Technical
  • Relative Strength Index (RSI)
  • EDSA 55.09
  • ISPO 45.87
  • Support Level
  • EDSA $2.03
  • ISPO $3.45
  • Resistance Level
  • EDSA $2.11
  • ISPO $3.87
  • Average True Range (ATR)
  • EDSA 0.10
  • ISPO 0.37
  • MACD
  • EDSA 0.01
  • ISPO -0.02
  • Stochastic Oscillator
  • EDSA 73.33
  • ISPO 17.41

About EDSA Edesa Biotech Inc.

Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.

About ISPO Inspirato Incorporated

Inspirato Inc is a private, luxury hospitality club that provides its members with access to an exclusive portfolio of high-end vacation homes, luxury hotels, and curated travel experiences worldwide. The club offers personalized service, dedicated trip planning, and seamless access to exceptional properties through its innovative model designed to ensure the service, certainty and value that discerning customers demand. The Inspirato portfolio of curated luxury vacation options includes approximately 350 private luxury vacation homes and accommodations at over 220 luxury hotel and resort partners in over 180 destinations around the world.

Share on Social Networks: